Natriuretic peptides in therapy for decompensated heart failure

European Journal of Clinical Pharmacology

Volumn 68, Issue 3, 2012, Pages 223-230

  Gassanov, Natig ^a   Biesenbach, Esther ^a   Caglayan, Evren ^a   Nia, Amir ^a   Fuhr, Uwe ^a   Er, Fikret ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Heart failure; Natriuretic peptides; Nesiritide; Urodilatin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; GLYCERYL TRINITRATE; HORMONE RECEPTOR; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR 1; NATRIURETIC PEPTIDE RECEPTOR 2; NATRIURETIC PEPTIDE RECEPTOR 3; NATRIURETIC PEPTIDE TYPE C; NATRIURETIC PEPTIDE TYPE D; NESIRITIDE; PLACEBO; UNCLASSIFIED DRUG; URODILATIN;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ANP GENE; AREA UNDER THE CURVE; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EARLY INTERVENTION; GENE PRODUCT; HEMODYNAMICS; HUMAN; HYPOTENSION; MAXIMUM PLASMA CONCENTRATION; MORTALITY; MULTIPLE CYCLE TREATMENT; NAUSEA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

HEART FAILURE; HUMANS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDES; RECOMBINANT PROTEINS; VASODILATOR AGENTS;

EID: 84857036386     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1117-1     Document Type: Review

References (37)

1. MB Anand-Srivastava MR Sairam M Cantin 1990 Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system J Biol Chem 265 8566 8572 2160462 1:CAS:528:DyaK3cXksFejsbs%3D
2. AJ Burger DP Horton T LeJemtel, et al. 2002 Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study Am Heart J 144 1102 1108 12486437 10.1067/mhj.2002.125620 1:CAS:528:DC%2BD3sXnvFWk (Pubitemid 36026926)
3. JC Burnett Jr PC Kao DC Hu, et al. 1986 Atrial natriuretic peptide elevation in congestive heart failure in the human Science 231 1145 1147 2935937 10.1126/science.2935937 (Pubitemid 16016312)
4. J Carstens KT Jensen EB Pedersen 1998 Metabolism and action of urodilatin infusion in healthy volunteers Clin Pharmacol Ther 64 73 86 9695722 10.1016/S0009-9236(98)90025-X 1:CAS:528:DyaK1cXltlarsrc%3D (Pubitemid 28377333)
5. WS Colucci U Elkayam DP Horton, et al. 2000 Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 246 253 10911006 10.1056/ NEJM200007273430403 1:CAS:528:DC%2BD3cXlvVSmtLw%3D (Pubitemid 30490392)
6. BB Das R Solinger 2009 Role of natriuretic peptide family in cardiovascular medicine Cardiovasc Hematol Agents Med Chem 7 29 42 19149542 10.2174/187152509787047630 1:CAS:528:DC%2BD1MXks1Wjtbs%3D
7. JA de Lemos DK McGuire MH Drazner 2003 B-type natriuretic peptide in cardiovascular disease Lancet 362 316 322 12892964 10.1016/S0140-6736(03)13976-1 (Pubitemid 36936846)
8. TA DeWald AF Hernandez 2010 Efficacy and safety of nesiritide in patients with acute decompensated heart failure Expert Rev Cardiovasc Ther 8 159 169 20136602 10.1586/erc.09.173 1:CAS:528:DC%2BC3cXhs1yltrY%3D
9. D Elsner F Muders A Muntze, et al. 1995 Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure Am Heart J 129 766 773 7900630 10.1016/0002-8703(95)90328-3 1:STN:280:DyaK2M3gvVGksg%3D%3D
10. AF Hernandez CM O'Connor RC Starling, et al. 2009 Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) Am Heart J 157 271 277 19185633 10.1016/j.ahj.2008.07. 031 1:CAS:528:DC%2BD1MXhtlSktrY%3D
11. RE Hobbs LW Miller C Bott-Silverman, et al. 1996 Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 78 896 901 8888662 10.1016/S0002-9149(96)00464-X 1:STN:280:DyaK2s%2FktlGruw%3D%3D (Pubitemid 126658650)
12. RE Hobbs RM Mills 1999 Therapeutic potential of nesiritide (recombinant b-type natriuretic peptide) in the treatment of heart failure Expert Opin Investig Drugs 8 1063 1072 15992106 10.1517/13543784.8.7.1063 1:CAS:528:DyaK1MXktlOltr4%3D (Pubitemid 29329038)
13. GM Keating KL Goa 2003 Nesiritide: a review of its use in acute decompensated heart failure Drugs 63 47 70 12487622 10.2165/00003495-200363010- 00004 1:CAS:528:DC%2BD3sXhtVSntbY%3D (Pubitemid 36132513)
14. DE Lanfear 2010 Genetic variation in the natriuretic peptide system and heart failure Heart Fail Rev 15 219 228 18850266 10.1007/s10741-008-9113-y 1:CAS:528:DC%2BC3cXksVeisLw%3D
15. TA McDonagh SD Robb DR Murdoch, et al. 1998 Biochemical detection of left-ventricular systolic dysfunction Lancet 351 9 13 9433422 10.1016/S0140-6736(97)03034-1 1:STN:280:DyaK1c%2FpsFSjtQ%3D%3D (Pubitemid 28020159)
16. A Meirhaeghe MS Sandhu MI McCarthy, et al. 2007 Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations Hum Mol Genet 16 1343 1350 17412758 10.1093/hmg/ddm084 1:CAS:528:DC%2BD2sXnsl2jtbo%3D (Pubitemid 47055130)
17. P Michels J Tarnow 2001 Natriuretic peptides: physiological, pathophysiological and clinical aspects Anasthesiol Intensivmed Notfallmed Schmerzther 36 406 416 11496615 10.1055/s-2001-15433 1:STN:280: DC%2BD3MvltFOisQ%3D%3D (Pubitemid 32666874)
18. RM Mills TH LeJemtel DP Horton, et al. 1999 Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group J Am Coll Cardiol 34 155 162 10400005 10.1016/S0735-1097(99)00184-9 1:CAS:528:DyaK1MXmvFaltb8%3D
19. V Mitrovic AF Hernandez M Meyer M Gheorghiade 2009 Role of guanylate cyclase modulators in decompensated heart failure Heart Fail Rev 14 309 319 19568931 10.1007/s10741-009-9149-7 1:CAS:528:DC%2BD1MXhtlKju73J
20. V Mitrovic H Luss K Nitsche, et al. 2005 Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial Am Heart J 150 1239 16338265 10.1016/j.ahj.2005.01.022 (Pubitemid 41773529)
21. V Mitrovic PM Seferovic D Simeunovic, et al. 2006 Haemodynamic and clinical effects of ularitide in decompensated heart failure Eur Heart J 27 2823 2832 17074775 10.1093/eurheartj/ehl337 1:CAS:528:DC%2BD2sXptVaksg%3D%3D (Pubitemid 44871466)
22. JG Motwani H McAlpine N Kennedy AD Struthers 1993 Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction Lancet 341 1109 1113 8097802 10.1016/0140-6736(93) 93126-L 1:STN:280:DyaK3s3kslenug%3D%3D (Pubitemid 23125853)
23. T Nakayama M Soma S Saito, et al. 2003 Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction Med Sci Monit 9 CR505 CR510 14646971 1:CAS:528:DC%2BD2cXnsleluw%3D%3D
24. T Nakayama M Soma Y Takahashi, et al. 2000 Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese Circ Res 86 841 845 10785505 1:CAS:528:DC%2BD3cXjtVehtbw%3D (Pubitemid 30246980)
25. JA Noviasky M Kelberman KM Whalen R Guharoy W Darko 2003 Science or fiction: use of nesiritide as a first-line agent? Pharmacotherapy 23 1081 1083 12921256 10.1592/phco.23.8.1081.32882 (Pubitemid 36904010)
26. CM O'Connor RC Starling AF Hernandez, et al. 2011 Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 32 43 21732835 10.1056/NEJMoa1100171
27. T Ogawa M Vatta BG Bruneau AJ de Bold 1999 Characterization of natriuretic peptide production by adult heart atria Am J Physiol 276 H1977 H1986 10362678 1:CAS:528:DyaK1MXksVWnurw%3D
28. MV Pitzalis R Sarzani P Dessi-Fulgheri, et al. 2003 Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype J Hypertens 21 1491 1496 12872042 10.1097/00004872-200308000-00012 1:CAS:528:DC%2BD3sXlvFarsbY%3D (Pubitemid 36994127)
29. LR Potter S Abbey-Hosch DM Dickey 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions Endocr Rev 27 47 72 16291870 10.1210/er.2005-0014 1:CAS:528:DC%2BD28XitFSit7c%3D (Pubitemid 43228238)
30. H Ruskoaho 1992 Atrial natriuretic peptide: synthesis, release, and metabolism Pharmacol Rev 44 479 602 1480667 1:CAS:528:DyaK3sXhvVentrY%3D
31. JD Sackner-Bernstein M Kowalski M Fox K Aaronson 2005 Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials Jama 293 1900 1905 15840865 10.1001/jama.293.15.1900 1:CAS:528:DC%2BD2MXjtl2gs7g%3D (Pubitemid 40548187)
32. JD Sackner-Bernstein HA Skopicki KD Aaronson 2005 Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 1487 1491 15781736 10.1161/01.CIR.0000159340.93220.E4 1:CAS:528:DC%2BD2MXisVGrtLg%3D (Pubitemid 40470642)
33. MA Silver A Maisel CW Yancy, et al. 2004 BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases Congest Heart Fail 10 1 30 10.1111/j.1527-5299.2004.03271.x 1:CAS:528:DC%2BD2cXpsFSnsLk%3D
34. AT Tong MA Rozner 2009 The role of nesiritide in heart failure Expert Opin Drug Metab Toxicol 5 823 834 19538002 10.1517/17425250903042300 1:CAS:528:DC%2BD1MXnsFamsLY%3D
35. A Vichiendilokkul A Tran E Racine 2003 Nesiritide: a novel approach for acute heart failure Ann Pharmacother 37 247 258 12549957 10.1345/aph.1A370 1:CAS:528:DC%2BD3sXhsFCjtrs%3D (Pubitemid 36172868)
36. CW Yancy H Krum BM Massie, et al. 2008 Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial Circ Heart Fail 1 9 16 19808265 10.1161/CIRCHEARTFAILURE.108.767483 1:CAS:528:DC%2BD1cXosFGnsLk%3D
37. JB Young WT Abraham LW Stevenson, et al. 2002 Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 1531 1540 10.1001/jama.287.6.772 1:CAS:528:DC%2BD38XisVegt74%3D (Pubitemid 34269998)